Total planned funding: $15,003,288
Allocations
Countries/Regions
Central Asia Region | $15,003,288 |
Organizational Types
Own Agency | $15,003,288 |
Program Areas
Management and Operations | $11,762,847 |
Prevention | $1,146,895 |
Governance and Systems | $1,003,743 |
Care | $477,710 |
Testing | $340,137 |
Treatment | $271,956 |
Budget Codes
HVMS: Management and Operations | $11,762,847 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $841,694 |
HLAB: Laboratory Infrastructure | $435,743 |
HBHC: Care: Adult Care and Support | $397,934 |
HVSI: Strategic Information | $354,268 |
HVCT: Testing: HIV Testing and Counseling | $340,137 |
HTXS: Treatment: Adult Treatment | $271,956 |
OHSS: Health Systems Strengthening | $213,732 |
HVOP: Sexual Prevention: Other Sexual Prevention | $204,623 |
HVTB: Care: TB/HIV | $79,776 |
HMBL: Biomedical Prevention: Blood Safety | $50,289 |
HMIN: Biomedical Prevention: Injection Safety | $50,289 |
Top Partner Programs
USG Aggregated Agencies:
$9,226,288
Countries/Regions
Central Asia Region
2011 | $5,099,999 |
2016 | $4,126,289 |
U.S. Centers for Disease Control and Prevention:
$3,238,500
Countries/Regions
Central Asia Region
2013 | $3,238,500 |
U.S. Agency for International Development:
$2,538,500
Countries/Regions
Central Asia Region
2013 | $2,538,500 |